MTX vs etanercept vs combo in PsA
ACR20 at 24 wks: 50%, 60%, 65%
Contrast TEMPO study in RA where combo therapy was better than monotherapy
Also: MTX monotherapy effective
Abs L11
Roundup – Cush, Kavanaugh #ACR18 @RheumNow

— D White (@WIRheum) October 24, 2018

Pooled analysis from 3 PSA+12 PSO trials on ixekizumab RCTs. Reassuring that incidence of IBD relatively low with significant pt year f/u (https://t.co/icWfGIEnxt @RheumNow #ACR18

— Dr. Arthur Lau (@ArthurRheum) October 24, 2018

ETN plus MTX combo better for skin PSO outcomes, but not a huge improvement for joints… but remember this study used ETN 50 q week (not twice weekly like used for PSO) @RheumNow

— Dr. Arthur Lau (@ArthurRheum) October 24, 2018

Dr. Cush
ABSTRACT: L11
Etanercept & MTX As Monotherapy or in Combination in Patients with Psoriatic Arthritis: A Phase 3, Double-Blind, Randomized Controlled Study —Addition of MTX to ETN did not improve efficacy compared with ETN alone. #ACR18 @Rheumnowhttps://t.co/6y8OTEVgPB

— Suleman Bhana, MD (@DrBhana) October 24, 2018